Johnson & Johnson (JNJ)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Johnson & Johnson (JNJ) is up 25.0% since the beginning of the year. At $256 per share, JNJ is trading 6.9% below its 52-week high of $275. Investors who bought $1,000 worth of JNJ shares 5 years ago would now be looking at an investment worth $1,710.

Johnson & Johnson (JNJ) has returned 24.99% so far this year and 56.77% over the past 12 months. Over the last ten years, JNJ has returned 10.37% per year, falling short of the S&P 500 Index benchmark, which averaged 13.10% annually.

Based on dividend-adjusted daily data since Jan 2, 1970, JNJ's average daily return is +0.06%, while the average monthly return is +1.14%. At this rate, an investment would double in approximately 5.1 years.

Historically, 58% of months were positive and 42% were negative. The best month was Feb 1975 with a return of +21.2%, while the worst month was May 1984 at -17.4%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 9 months.

On a daily basis, JNJ closed higher 49% of trading days. The best single day was Oct 13, 2008 with a return of +12.2%, while the worst single day was Oct 19, 1987 at -18.4%.

Johnson & Johnson has an annualized alpha of 7.84%, beta of 0.71, and R2 of 0.29 versus S&P 500 Index. Calculated based on daily prices since January 02, 1970.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (84.39%) than losses (63.03%) - typical of diversified or defensive assets.
• R2 of 0.29 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

JNJ ranks 97 for risk / return — above 97% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.

Johnson & Johnson provided a 2.05% dividend yield over the last twelve months, with an annual payout of $5.24 per share. The company has been increasing its dividends for 25 consecutive years, earning it the status of a dividend aristocrat.

The table displays the monthly dividend distributions for Johnson & Johnson. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Johnson & Johnson. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Johnson & Johnson was 50.67%, occurring on Apr 25, 1977. Recovery took 1034 trading sessions.

The current Johnson & Johnson drawdown is 4.27%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Johnson & Johnson over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Johnson & Johnson is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.